TSC2 and tuberous sclerosis: In LAM or TSC models, the SASP cytokine IL-6 has been better studied than IL-8, demonstrating an increase in TSC2-deficient cells in an mTORC1-dependent manner and an up-regulation in plasma of LAM patients compared to healthy subjects [28].